Overview

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of BI-505 on tumor burden in patients diagnosed with smoldering multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
BioInvent International AB